Related Experiment Videos
Recent acquisitions in pain therapy: meclofenamic acid
1Department of Physiopathology and Pain Therapy, University of Milan, Italy.
The Clinical Journal of Pain
|January 1, 1991
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDs) offer better pain relief through central nervous system actions and substance P inhibition. Understanding patient factors is key for safe and effective NSAID use in conditions like headache and rheumatic disease.
Area of Science:
- Pharmacology
- Pain Management
- Rheumatology
Background:
- Recent pharmacodynamic and pharmacokinetic studies enhance understanding of nonsteroidal anti-inflammatory drugs (NSAIDs).
- NSAIDs' analgesic effects may originate in the central nervous system (CNS).
- The onset of analgesic action is often faster than anti-inflammatory effects, even at lower doses.
Purpose of the Study:
- To explore the improved utilization of NSAIDs based on current scientific understanding.
- To investigate the pharmacologic and clinical profile of meclofenamic acid for optimized therapeutic outcomes.
Main Methods:
- Review of pharmacodynamic and pharmacokinetic data for NSAIDs.
- Analysis of NSAIDs' mechanisms, including central nervous system effects and substance P inhibition.
- Clinical case review focusing on meclofenamic acid's behavior.
Main Results:
- NSAIDs exhibit analgesic action potentially within the CNS, occurring earlier than anti-inflammatory effects.
- Some NSAIDs elevate plasmatic beta-endorphin levels in humans.
- NSAIDs possess antiprostaglandin activity and may inhibit substance P release, contributing to pain relief.
Conclusions:
- NSAIDs are valuable for managing pain associated with headache, dysmenorrhea, rheumatic diseases, and cancer.
- Safe and effective NSAID use requires careful consideration of patient history and clinical presentation.
- Meclofenamic acid's pharmacologic and clinical properties warrant examination for optimal therapeutic application.